We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,857

China updates blacklist system to combat commercial bribery in health care
  • HaoLiWen
  • China
  • February 7 2014

Recently, the China National Health and Family Planning Commission ( the "Commission") issued the Rules on Establishing Commercial Bribery Blacklists

WHO issues global alert on new strain of avian influenza (H7N9)
  • Shook Hardy & Bacon LLP
  • China, Global, USA
  • April 12 2013

The World Health Organization (WHO) has issued a global alert and response update on a new strain of novel avian influenza A (H7N9) virus identified

China allows (limited) registrations for retail and distribution services
  • Wilkinson & Grist
  • China
  • March 6 2013

As of 1st January 2013, China is allowing the registration of trademarks in connection with the retail and distribution of several medicine-related

China issues new rules to tackle conflict of interest of healthcare government officials
  • Sidley Austin LLP
  • China
  • January 12 2012

On December 26, the Chinese Ministry of Health (MOH) issued the Rules on Prohibition of Conflict of Interest for Healthcare Officials

Chinese government publishes Vaccine Supply System Development Plan
  • Sidley Austin LLP
  • China
  • January 11 2012

On December 22, the State Council of China published the Vaccine Supply System Development Plan

Life Sciences Health Industry China Briefing - April 2012
  • Reed Smith LLP
  • China
  • May 21 2012

Reed Smith’s Life Sciences Health Industry China Briefing provides a summary of the monthly news and legal developments relating to China's Pharmaceutical, Medical Device, and Life Sciences Health Care Industries

Twelfth Five-Year (2011-2015) plan for medical device and equipment industry
  • Greenberg Traurig LLP
  • China
  • April 2 2012

The PRC Ministry of Science and Technology (MOST) issued the Twelfth Five-Year (2011-2015) Specific Plan for Medical Device and Equipment Industry (the “Medical Plan”) on January 19, 2012

China encourages pharmaceutical companies to timely pursue new GMP certification
  • Sidley Austin LLP
  • China
  • January 15 2013

In 2010, China's State Food and Drug Administration ("SFDA") issued a new version of its Good Manufacturing Practice (the "GMP") regulations, which

Chinese FDA soliciting public comments on rules for re-packaging of IVDs
  • Ropes & Gray LLP
  • China
  • November 14 2012

The State Food and Drug Administration (“SFDA”) in China published a draft of the Tentative Measures for the Administration of the Registration of Re-Packaging In-Vitro Devices (IVDs) (“Draft Measures”) on November 2 for public comments through November 20

China issues human genetic resources management regulations
  • Foley & Lardner LLP
  • China
  • November 18 2012

Those seeking to conduct research involving human genetic material within the People’s Republic of China or to import into China such material should review China’s recently issued draft regulations (“Draft”) for the management of its human genetic resources